Text Size: [+] [-]

Medical Research at Inova

Inova's commitment to research and innovation focuses on bringing new treatments to the patient’s bedside safely and quickly, advancing clinical innovation in Northern Virginia and beyond.

A foundation for Inova's research vision is the Inova Translational Medicine Institute (ITMI) – a not-for-profit research institute delving into the next frontier of healthcare innovation: personalized medicine.

Personalized medicine emphasizes the customization of healthcare to individual patients. It involves the use of genetic information about an individual patient. The future of patient care lies in understanding the genomic makeup of individual patients to help prevent or manage their diseases. ITMI is helping pave the way for that future.

In addition, Inova sponsors numerous research studies conducted by our nationally recognized researchers in collaboration with other healthcare organizations, major universities and global pharmaceutical and biomechanics companies.

Explore Inova's research frontiers

News & Expert Commentary 

Data from NIH/NHLBI-Sponsored Phase 2 Trial of Fostamatinib in Hospitalized COVID-19 Patients Published in Clinical Infectious Diseases... Read More
September 1, 2021
Diversity and Inclusion in Clinical Trials... Read More
May 19, 2021
Inova’s Breast Cancer Team Takes a New Look at Hormone Therapy Treatment... Read More
February 3, 2021
Review of Inova COVID-19 Cases Lends Insight into Ventilator Mortality Risks... Read More
December 28, 2020
Inova’s Dr. Aragon-Ching Part of International Team Showing Benefit of Immunotherapy in Bladder Cancer Treatment... Read More
September 24, 2020
View More...